Comparative analysis reveals both APS and PSP target neuroinflammation through distinct mechanisms: (1) APS directly suppresses cytokine production (IL-6/TNF-α/IL-2), whereas (2) PSP activates PPAR-γ-mediated transcriptional regulation. The gene discussed is IL2; the disease is autoimmune polyendocrinopathy.